semaglutide and type 1 diabetes tirzepatide treatment leads to weight loss in GLP-1 Drugs and Type 1

BPC-157 and TB-500 are my favorites, I lean on them for inflammation, and neither is FDA-approved yet

Weeks 16-56: Steady weight loss continues but gradually slows as you approach a new equilibrium

Do you have to take it forever

They may also improve blood flow to the brain, further supporting healthy brain function. A reduced risk of heart attacks These medications appear to lower your chance of life-threatening heart-health events

Months 36: Active Weight Loss Phase This is typically the period of fastest weight loss as the dose reaches therapeutic levels (1.7 mg or 2.4 mg/week for Wegovy)

There are currently no reports of the psychiatric adverse reaction to tirzepatide